Internal Medicine
[Abstract Only] Randomized trial tests metformin in women with type 2 diabetes in pregnancy
28 Sep, 2020 | 01:30h | UTCCommentary: Welcome news for pregnant women with type 2 diabetes – MedicalXpress
Commentary on Twitter
https://twitter.com/TIME_research/status/1306856108338933765
Randomized trial: Gabapentin not effective for chronic pelvic pain in women
28 Sep, 2020 | 01:25h | UTCCommentary: Common pelvic pain drug is ineffective, study finds – University of Edinburgh
Commentary on Twitter
1/5 Pleased to announce publication of our @GaPP2_trial in @lancet today – the largest ever study into treatment for female chronic pelvic pain @exppect @MRC_CRH @EdinUniMedicine @EdinUniMedia @NIHRresearch @BhamCTU @GynaeResearcher https://t.co/NYEAxo2VAh https://t.co/A0ZOr8gqc3 pic.twitter.com/zwn8F7KRHO
— Andrew Horne (@horne_research) September 25, 2020
Falling COVID-19 viral loads may explain lower rates of ICU use, deaths
25 Sep, 2020 | 02:45h | UTCFalling COVID-19 viral loads may explain lower rates of ICU use, deaths – CIDRAP
[Abstract Only] Meta-analysis: Direct oral anticoagulants for cancer-associated venous thromboembolism
28 Sep, 2020 | 01:22h | UTC
Gastrointestinal complications in critically ill patients with and without COVID-19
25 Sep, 2020 | 02:44h | UTCGastrointestinal Complications in Critically Ill Patients With and Without COVID-19 – JAMA
Commentary on Twitter
https://twitter.com/LMaurerMD/status/1309185925692481536
Small randomized trial evaluated intravenous methylprednisolone pulse as a treatment for hospitalized severe COVID-19 patients
25 Sep, 2020 | 02:41h | UTC
Understanding necrotizing soft tissue infections in the intensive care unit
25 Sep, 2020 | 02:31h | UTC
Commentary on Twitter
Necrotizing soft tissue infections in #ICU, focus on optimizing interventions most likely to impact outcome:
➡️ keep high index of suspicion vs misdiagnosis/delays in starting treatment
➡️ coordinate urgent approach: early debridement + broad-spectrum ABThttps://t.co/NpkxYFHbGl pic.twitter.com/8LDQuOGobI— Intensive Care Medicine (@yourICM) September 22, 2020
Randomized trial: Dapagliflozin in patients with chronic kidney disease
25 Sep, 2020 | 02:34h | UTCDapagliflozin in Patients with Chronic Kidney Disease – New England Journal of Medicine (free for a limited period)
Commentary: Dapagliflozin Cuts Renal Risks in Patients with CKD, Regardless of Diabetes Status – NEJM Journal Watch
New CDC recommendations for meningococcal vaccination
25 Sep, 2020 | 02:33h | UTC
JAMA Network Series: Medical Specialties and the COVID-19 Pandemic
24 Sep, 2020 | 09:45h | UTCEditorial: The COVID-19 Pandemic and the JAMA Network
See articles:
- Cardiology and COVID-19
- Dermatology and COVID-19
- Internal Medicine and COVID-19
- Nephrology and COVID-19
- Neurology and COVID-19
- Oncology and COVID-19
- Ophthalmology and COVID-19
- Otolaryngology–Head and Neck Surgery and COVID-19
- Pediatrics and COVID-19
- Psychiatry and COVID-19
- Surgery and COVID-19
- JAMA Network Open and COVID-19
- JAMA Health Forum and COVID-19
As their numbers grow, COVID-19 “long haulers” stump experts
24 Sep, 2020 | 09:33h | UTCAs Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts – JAMA
Commentary on Twitter
Many #COVID19 long haulers didn’t require hospitalization, let alone ICU stays. Researchers suspect #SARSCoV2 can trigger long-lasting changes in the immune system, especially in the lungs, which may persist long after patients stop shedding the virus https://t.co/UuRr0LbLy5
— JAMA (@JAMA_current) September 24, 2020
The BMJ interview: Anthony Fauci on Covid-19
24 Sep, 2020 | 09:36h | UTCThe BMJ interview: Anthony Fauci on covid-19 – The BMJ
Commentary on Twitter
Anthony Fauci, one of the world’s most respected infectious disease experts, speaks with The BMJ’s @fgodlee about the pressures of advising the US president, the challenging nature of the new coronavirus, and how the pandemic might endhttps://t.co/4CuMFTEiKl @NIAIDNews
— The BMJ (@bmj_latest) September 23, 2020
Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection
24 Sep, 2020 | 09:32h | UTCCommentary: Simple blood test can predict severity of COVID-19 for some patients – University of Texas Health Science Center at Houston AND Routine blood test may identify patients at risk for severe COVID-19 – UPI
Commentary on Twitter
Death in #COVID19: JAMA Open
In lots of dzs RDW >14.5% robustly risk stratifies pts w/in illness. True in #COVID! Mortality w/ nl RDW 11% vs. 31% with high RDW (9% ⬆️ risk per 0.5% increase in RDW). BEST predictor next to Age!https://t.co/aZJ3p488cN#medtwitter #tipsfornewdocs pic.twitter.com/967g2HElYH— WesElyMD (@WesElyMD) September 23, 2020
COVID-19 can affect the heart
24 Sep, 2020 | 09:30h | UTCCOVID-19 can affect the heart – Science
Commentary on Twitter
"These complications, which at times are the only features of #COVID19 clinical presentation, have occurred even in cases with mild symptoms and in people who did not experience any symptoms" https://t.co/q42cY3ujV4
a 🧵to explain 1/— Eric Topol (@EricTopol) September 24, 2020
Meta-analysis: Central fatness and risk of all-cause mortality
24 Sep, 2020 | 09:19h | UTC
Commentary on Twitter
https://twitter.com/bmj_latest/status/1308909015867494400
Things we do for no reason: Routine correction of elevated INR and thrombocytopenia prior to paracentesis in patients with cirrhosis
24 Sep, 2020 | 09:17h | UTCSee collection: Choosing Wisely: Things We Do For No Reason – Journal of Hospital Medicine
Diagnostic test interpretation: Coronary computed tomography angiography
24 Sep, 2020 | 09:14h | UTCCoronary Computed Tomography Angiography – JAMA (free for a limited period)
[Preprint] Randomized trial: Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers
23 Sep, 2020 | 14:17h | UTC
Commentary on Twitter
🔥 #Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial 🔥
-1st RCT on HCQ as PrEP
-1483 HCW randomized to HCQ 1x or 2x weekly or placebo
-No difference in development of confirmed or probable COVID19 https://t.co/Gn1otqKhrW pic.twitter.com/3r0HB56h9y
— Ilan Schwartz is on🦋 (@GermHunterMD) September 21, 2020
COVID-19 clinical trials: Learning from exceptions in the research chaos
23 Sep, 2020 | 14:50h | UTCCOVID-19 clinical trials: learning from exceptions in the research chaos – Nature
Commentary on Twitter
Our analysis on #COVID clinical trials on Nature Medicine. Only big randomised trials can answer rapidly & reliably. Megatrials need support from regulators, funders, health services, docs. Pre-existing trial networks helpful. Collaboration key to success. https://t.co/YlalAEMR9r pic.twitter.com/wElfXfXdol
— Kari Tikkinen (@KariTikkinen) September 22, 2020
NICE Guideline: Low back pain and sciatica in over 16s
23 Sep, 2020 | 14:41h | UTC
USPSTF draft statement: Insufficient evidence to screen for Vitamin D deficiency in asymptomatic adults
23 Sep, 2020 | 14:36h | UTC
NICE Guideline: Antimicrobial prescribing for insect bites and stings
23 Sep, 2020 | 14:40h | UTC
Cardiac arrhythmias in critically ill patients with COVID-19: A brief review
22 Sep, 2020 | 09:59h | UTC
Catheter-associated urinary tract infections in adults: diagnosis, treatment, and prevention
23 Sep, 2020 | 14:35h | UTCCatheter-Associated Urinary Tract Infections in Adults: Diagnosis, Treatment, and Prevention – Journal of Hospital Medicine (free for a limited period)
What can we expect from first-generation COVID-19 vaccines?
22 Sep, 2020 | 10:02h | UTCWhat can we expect from first-generation COVID-19 vaccines? – The Lancet
Commentary on Twitter
We need to calibrate our expectations for the 1st generation of #SARSCoV2 vaccines https://t.co/QTJbyOd9xQ @TheLancet by @gmleunghku and Malik Peiris @hkumed Pe-covid normalcy is not near. pic.twitter.com/Y15TqfoRlf
— Eric Topol (@EricTopol) September 21, 2020